Management strategies for hormonal replacement therapy.
Every year for the next 10 years, approximately 4 million women will become perimenopausal. For these women an important decision is whether or not to use hormone replacement therapy (HRT), and if they decide affirmatively, then, for how long to use it. The health provider must be able to help the woman in her decision making process by identifying the risks, benefits, and contraindications to this therapy. This information, based on the latest research, is presented in this article along with the types of hormones available, prescription regimens, side effects, management issues, and possible alternatives to hormone therapy.
Scharbo-DeHaan
M
M
Emory University School of Nursing, Nurse Midwifery Program, Atlanta, GA.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002979:Climacteric / Q000187:drug effects; D000075202:Contraindications; D003692:Delayed-Action Preparations; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004967:Estrogens / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D011372:Progestins / Q000008:administration & dosage; D013923:Thromboembolism / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000139:chemically induced
D003692:Delayed-Action Preparations; D004967:Estrogens; D011372:Progestins